Xenon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $26.74-$44.23 |
Market Cap | $3.2B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $7.5M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$265.2M |
Diluted EPS | -$3.89 |
News
See moreYahoo Finance • 19 hours ago
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
Yahoo Finance • last month
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
Yahoo Finance • 2 months ago
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
Address | 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 316 |
